# INtra-arterial AltEplase folloWing successfuL reperfusIoN After mEchanical Thrombectomy

Study · id `cardio:ct-nct07727395` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07727395](<https://clinicaltrials.gov/study/NCT07727395>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07727395

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 416 participants.

## Technical summary

Registry record NCT07727395. Randomized; single masking; primary purpose treatment. Start 2026-08-01 (actual); primary completion 2028-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 416 participants (planned count; ClinicalTrials.gov record NCT07727395, source copy `cardio:ctgov-nct07727395-2026-11-09`, retrieved 2026-11-18)
- Started: 2026-08-01 (actual) (ClinicalTrials.gov record NCT07727395, source copy `cardio:ctgov-nct07727395-2026-11-09`, retrieved 2026-11-18)
- Primary completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT07727395, source copy `cardio:ctgov-nct07727395-2026-11-09`, retrieved 2026-11-18)
- Completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT07727395, source copy `cardio:ctgov-nct07727395-2026-11-09`, retrieved 2026-11-18)
- Countries: Vietnam (ClinicalTrials.gov record NCT07727395, source copy `cardio:ctgov-nct07727395-2026-11-09`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07727395-2026-11-09`, retrieved 2026-11-18)

## The registry's words

- Brief title: INtra-arterial AltEplase folloWing successfuL reperfusIoN After mEchanical Thrombectomy
- Acronym: NEWLINE
- Condition: Stroke, Acute Ischemic
- Condition: Large Vessel Occlusion
- Condition: Thrombectomy
- Intervention (Drug): Alteplase
- Intervention (Device): Endovascular thrombectomy
- Lead sponsor: 115 People's Hospital
- Lead sponsor class: OTHER\_GOV
- Collaborator: Ho Chi Minh City Stroke Association
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 84cc349389cf495db8c8b71a5676a6b0b97887adbf71744742bb2f95981f1ae9
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
